Pulmatrix, Inc. (NASDAQ:PULM – Get Free Report)’s share price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $2.06 and traded as high as $2.06. Pulmatrix shares last traded at $2.00, with a volume of 3,923 shares traded.
Wall Street Analysts Forecast Growth
Separately, StockNews.com started coverage on shares of Pulmatrix in a report on Friday. They set a “hold” rating on the stock.
View Our Latest Analysis on PULM
Pulmatrix Stock Down 2.4 %
Pulmatrix (NASDAQ:PULM – Get Free Report) last posted its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($0.87) earnings per share (EPS) for the quarter. The firm had revenue of $1.55 million for the quarter. Pulmatrix had a negative net margin of 95.18% and a negative return on equity of 46.86%.
About Pulmatrix
Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Further Reading
- Five stocks we like better than Pulmatrix
- Insider Trades May Not Tell You What You Think
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Short Selling: How to Short a Stock
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Pulmatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulmatrix and related companies with MarketBeat.com's FREE daily email newsletter.
